(19)
(11) EP 2 000 115 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.09.2011 Bulletin 2011/39

(45) Mention of the grant of the patent:
04.05.2011 Bulletin 2011/18

(21) Application number: 08016624.2

(22) Date of filing: 31.12.1997
(27) Previously filed application:
 31.12.1997 EP 05024006
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
 B60K 37/06(2006.01)

(54)

A prosthetic valve assembly

Herzklappenprothesenanordnung

Ensemble de valve prothétique

(84) Designated Contracting States:
DE ES FR IT NL

(30) Priority: 31.12.1996 EP 96402929

(43) Date of publication of application:
10.12.2008 Bulletin 2008/50

(60) Divisional application:
10012626.7 / 2260796
10012627.5 / 2260797
10012954.3 / 2263609
10184036.1 / 2260798

(62) Application number of the earlier application in accordance with Art. 76 EPC:
05024006.8 / 1621162
97953935.0 / 0967939

(73) Proprietor: Edwards Lifesciences PVT, Inc.
Irvine, CA 92614 (US)

(72) Inventors:
  • Letac, Brice
    deceased (FR)
  • Cribier, Alain
    76570 Pavilly (FR)

(74) Representative: Vaillant, Jeanne et al
Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber
75009 Paris
75009 Paris (FR)


(56) References cited: : 
WO-A-93/01768
WO-A1-96/40008
US-A- 3 657 744
US-A- 4 692 164
 WO-A-94/12136
US-A- 3 548 417
US-A- 4 629 459
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).